Nefopam Hydrochloride Rivopharm Uk (Nefopam Hydrochloride)

Nefopam works by inhibiting the reuptake of the neurotransmitters norepinephrine, serotonin and dopamine, which enhances descending pain‑inhibitory pathways in the central nervous system. It also blocks voltage‑gated sodium channels, reducing neuronal excitability. The combined effect provides analgesia without engaging opioid receptors.

The dosage of Nefopam Hydrochloride is individualized by the prescribing clinician based on the severity of pain, patient characteristics, and local regulatory guidance. The prescriber determines the appropriate strength, frequency, and duration of therapy; no standardized dosing regimen is provided here.

Safety data for Nefopam Hydrochloride in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant. Clinicians should assess each case carefully and discuss possible risks with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request confirmation of trade or institutional credentials. The sales team will then provide pricing, availability, shipping details and any required import documentation.

Unlike opioids, Nefopam does not act on opioid receptors, reducing the risk of typical opioid‑related side effects such as respiratory depression, dependence and constipation. Its mechanism involves neurotransmitter reuptake inhibition and sodium‑channel blockade, offering effective analgesia for certain acute pain scenarios while avoiding opioid‑specific adverse events.

Nefopam Hydrochloride should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, excessive heat and direct sunlight. Do not store in a refrigerator or freezer unless specifically instructed by the manufacturer.

Nefopam Hydrochloride is administered orally. The tablet or capsule is swallowed whole with a glass of water, preferably with or without food as directed by the prescriber. Patients should follow the exact administration instructions provided by their healthcare professional.

Serious risks include the potential for seizures, severe hypotension, tachycardia, allergic reactions such as anaphylaxis, and rare dermatologic emergencies like Stevens‑Johnson syndrome. Patients should be monitored for any signs of these events, and therapy should be discontinued immediately if they occur.

Nefopam is contraindicated in patients with a known hypersensitivity to the drug, those with uncontrolled seizure disorders, and individuals currently taking monoamine oxidase inhibitors. Caution is also advised for patients with severe cardiovascular disease, hepatic or renal impairment, and those on interacting medications.